2013: Development Trends and Practical Aspects of the Pharmaceutical Industry
On 17 April, the Deloitte CIS Life Science & Health Care (LS&HC) industry group organised a breakfast round table for companies in the pharmaceutical industry. More than 60 people attended the event, including representatives of major companies in the sector. The round table offered participants a great opportunity to network, discuss current issues regarding the financial aspects of their industry and exchange their knowledge and experience.
Oleg Berezin, Head of the LS&HC industry group at Deloitte CIS, opened the event with a presentation about the main trends in the pharmaceutical market, asking whether there is any need for change in business strategies.
Afterwards, the president of a leading pharmaceutical company talked about the challenges and opportunities regarding Russian domestic pharmaceutical production. This talk was followed by a discussion of participants’ views and experiences.
Deloitte specialists delivered a number of informative presentations on topics such as the new transfer pricing legislation and practical examples of how companies are responding to it, the possibility of applying for state guarantees, and trends in the development of antitrust practice among pharmaceutical companies.